Indoco Remedies has announced that, it's sterile manufacturing facility (Plant II) at Verna, Goa, has successfully concluded an inspection conducted by the UK Health Regulator, MHRA. The inspection was held from 16th to 20th September 2019 and resulted in 2 observations.
Commenting on this positive development, Ms. Aditi Kare Panandikar, Managing Director - Indoco Remedies Ltd., said, "The successful closure of the MHRA inspection is encouraging and reflects the immense learning and adaption by our technical team.
The Sterile manufacturing site is expected to receive the EUGMP certification soon, following this recent inspection."
Shares of INDOCO REMEDIES LTD. was last trading in BSE at Rs.156.2 as compared to the previous close of Rs. 157.2. The total number of shares traded during the day was 1566 in over 159 trades.
The stock hit an intraday high of Rs. 164.9 and intraday low of 153.5. The net turnover during the day was Rs. 249079.